| Effect of acetazolamide on ventilatory response in subjects with chronic mountain sickness. | |
| | |
MedLine Citation:
|
PMID: 18603026 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Although the effects of acetazolamide (ACZ) on ventilation during acute mountain sickness are well known, there are no studies assessing its effect on ventilatory response in chronic hypoxia. We studied this effect in patients with chronic mountain sickness (CMS). Subjects with CMS, living permanently at 4300 m, were assigned in a randomized, double-blind study to 250 mg/day (n=9) or to 500 mg/day (n=9) of ACZ. Resting end-tidal PET(O2) and end-tidal PET(CO2) were measured before and after 3 weeks of acetazolamide. Ventilatory responses were evaluated by the determination of sensitivity to hypoxia and to CO2. After treatment ventilatory response to hypoxia increased, resting PET(CO2) decreased, and ACZ caused a leftward shift in the position, but not a change in the slope of the ventilation (VE) versus PET(CO2) relationship. There were no differences between the two doses used. ACZ administration provides a beneficial effect on respiratory function of high altitude natives with CMS and thus it can be an effective therapy for the disease. |
| | |
Authors:
|
Maria Rivera-Ch; Luis Huicho; Patrick Bouchet; Jean Paul Richalet; Fabiola León-Velarde |
Related Documents
:
|
2225896 - High-frequency oscillation during simulated altitude exposure. 23102906 - Foot pressure distribution variation in pre-obese and non-obese adult subject while sta... 7961246 - Effect of dopamine on hypoxic ventilatory response of sedated piglets with intact and d... 7124306 - Effect of supramaximal vagal stimulation in combination with hypoxia, respiratory acido... 10823336 - Forearm vascular responses during orthostatic stress in control subjects and patients w... 20840386 - The effects of l-659,066, a peripheral α2-adrenoceptor antagonist, and verapamil on th... |
Publication Detail:
|
Type: Journal Article; Randomized Controlled Trial Date: 2008-06-17 |
Journal Detail:
|
Title: Respiratory physiology & neurobiology Volume: 162 ISSN: 1569-9048 ISO Abbreviation: Respir Physiol Neurobiol Publication Date: 2008 Aug |
Date Detail:
|
Created Date: 2008-09-09 Completed Date: 2009-04-09 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101140022 Medline TA: Respir Physiol Neurobiol Country: Netherlands |
Other Details:
|
Languages: eng Pagination: 184-9 Citation Subset: IM |
Affiliation:
|
Departamento de Ciencias Biológicas y Fisiológicas, Facultad de Ciencias y Filosofía, Instituto de Investigaciones de Altura, Universidad Peruana Cayetano Heredia, Av. Honorio Delgado 430, Lima 31, Peru. mrivera@upch.edu.pe |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acetazolamide
/
therapeutic use* Adult Altitude Sickness / drug therapy*, physiopathology* Analysis of Variance Anoxia / physiopathology Anticonvulsants / therapeutic use* Carbon Dioxide / pharmacology Chronic Disease Dose-Response Relationship, Drug Double-Blind Method Humans Male Middle Aged Oxygen Respiratory Mechanics / drug effects*, physiology |
| Chemical | |
Reg. No./Substance:
|
0/Anticonvulsants; 124-38-9/Carbon Dioxide; 59-66-5/Acetazolamide; 7782-44-7/Oxygen |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The putative protective role of hepatitis B virus (HBV) infection from autoimmune disorders.
Next Document: Membrane-bound class III peroxidases: identification, biochemical properties and sequence analysis o...